AT293690T
5t4 tumour-associated antigen for use in tumour immunotherapy
Abstract
This record has no abstract on file.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
147 members in 18 offices
Priority claims4
| Document | Office | Kind | Date |
|---|---|---|---|
| 9825303 | United Kingdom | A | |
| 9901739 | United Kingdom | A | |
| 9917995 | United Kingdom | A | |
| 9903859 | United Kingdom | W |
Members147
| Document | Office | Kind | |
|---|---|---|---|
| GB9711579D0 | United Kingdom | D0 | |
| GB9713150D0 | United Kingdom | D0 | |
| GB9714230D0 | United Kingdom | D0 | |
| CA2292760A1 | Canada | A1 | |
| WO9855607A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU7780198A | Australia | A | |
| GB9825303D0 | United Kingdom | D0 | |
| WO9855607A3 | World Intellectual Property Organization (WIPO) | A3 | |
| GB9901739D0 | United Kingdom | D0 | |
| GB9917995D0 | United Kingdom | D0 | |
| NO995901D0 | Norway | D0 | |
| NO995901L | Norway | L | |
| GB0003527D0 | United Kingdom | D0 | |
| GB0005071D0 | United Kingdom | D0 | |
| CA2351622A1 | Canada | A1 | |
| WO0029428A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1394900A | Australia | A | |
| CN1258319A | China | A | |
| EP1012259A2 | European Patent Office (EPO) | A2 | |
| GB0014986D0 | United Kingdom | D0 | |
| EP1036091A1 | European Patent Office (EPO) | A1 | |
| GB2347932A | United Kingdom | A | |
| WO0029428A3 | World Intellectual Property Organization (WIPO) | A3 | |
| KR20010013219A | Republic of Korea | A | |
| IL132596D0 | Israel | D0 | |
| CA2391925A1 | Canada | A1 | |
| WO0136486A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1290001A | Australia | A | |
| KR20010084935A | Republic of Korea | A | |
| EP1152060A1 | European Patent Office (EPO) | A1 | |
| GB0122803D0 | United Kingdom | D0 | |
| EP1160323A1 | European Patent Office (EPO) | A1 | |
| GB0127669D0 | United Kingdom | D0 | |
| GB0127673D0 | United Kingdom | D0 | |
| GB0127675D0 | United Kingdom | D0 | |
| CN1333829A | China | A | |
| JP2002507117A | Japan | A | |
| WO0136486A3 | World Intellectual Property Organization (WIPO) | A3 | |
| AU747602B2 | Australia | B2 | |
| WO0238612A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU1415002A | Australia | A | |
| KR20020049054A | Republic of Korea | A | |
| GB2370571A | United Kingdom | A | |
| GB2370572A | United Kingdom | A | |
| GB2370573A | United Kingdom | A | |
| GB0212763D0 | United Kingdom | D0 | |
| GB2371803A | United Kingdom | A | |
| JP2002530060A | Japan | A | |
| EP1242456A2 | European Patent Office (EPO) | A2 | |
| NZ500633A | New Zealand | A | |
| GB0224538D0 | United Kingdom | D0 | |
| US2003018004A1 | United States of America | A1 | |
| GB2378704A | United Kingdom | A | |
| WO03025191A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU2002336162A1 | Australia | A1 | |
| US2003083290A1 | United States of America | A1 | |
| GB2347932B | United Kingdom | B | |
| GB2370571B | United Kingdom | B | |
| GB2370572B | United Kingdom | B | |
| GB2378704B | United Kingdom | B | |
| JP2003515323A | Japan | A | |
| WO0238612A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US2003103940A1 | United States of America | A1 | |
| CN1423660A | China | A | |
| WO03025191A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1347994A2 | European Patent Office (EPO) | A2 | |
| AU766954B2 | Australia | B2 | |
| GB0400443D0 | United Kingdom | D0 | |
| US2004081656A1 | United States of America | A1 | |
| EP1427836A2 | European Patent Office (EPO) | A2 | |
| US2004131591A1 | United States of America | A1 | |
| US2004265275A1 | United States of America | A1 | |
| JP2005503162A | Japan | A | |
| US6852703B1 | United States of America | B1 | |
| US2005032216A1 | United States of America | A1 | |
| EP1036091B1 | European Patent Office (EPO) | B1 | |
| AT293690TThis record | Austria | T | |
| ATE293690T1 | Austria | T1 | |
| DE69924826D1 | Germany | D1 | |
| WO2005065718A2 | World Intellectual Property Organization (WIPO) | A2 | |
| CN1224712C | China | C | |
| US2006014222A1 | United States of America | A1 | |
| DE69924826T2 | Germany | T2 | |
| CN1782072A | China | A | |
| WO2005065718A3 | World Intellectual Property Organization (WIPO) | A3 | |
| US7074909B2 | United States of America | B2 | |
| WO2005065718A8 | World Intellectual Property Organization (WIPO) | A8 | |
| EP1717248A1 | European Patent Office (EPO) | A1 | |
| EP1725252A2 | European Patent Office (EPO) | A2 | |
| US7148035B1 | United States of America | B1 | |
| US2006286634A1 | United States of America | A1 | |
| US2007014808A1 | United States of America | A1 | |
| CN1298851C | China | C | |
| US2007086992A1 | United States of America | A1 | |
| US2007128164A1 | United States of America | A1 | |
| US2007161080A1 | United States of America | A1 | |
| US7276488B2 | United States of America | B2 | |
| US2007259400A1 | United States of America | A1 | |
| US2007281898A1 | United States of America | A1 | |
| US2007298055A1 | United States of America | A1 |
Showing 100 of 147
2 legal events, as the office reported them to INPADOC
Over the term
Point at a mark for the eventEvents
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP | |
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99972219
Titles2
- German
- VERWENDUNG VOM KREBS-ASSOZIIERTEN ANTIGEN 5T4 ZUR IMMUNTHERAPIE
- English
- USE OF CANCER ASSOCIATED ANTIGEN 5T4 TO IMMUNE THERAPY
Classification
- CPC, 9
- C07K14/4748
- C12N15/863
- A61K38/00
- A61K39/00
- A61K48/00
- A61K2039/53
- A61P15/00
- C12N2799/023
- A61P35/00
- IPC, 11
- A61K38 00
- A61K39 00
- A61K48 00
- A61P15 00
- A61P35 00
- C07K14 065
- C07K14 47
- C07K19 00
- C07K7 06
- C12N15 09
- C12N15 12